CD274 and neoplasm: Intriguingly, it was recently demonstrated that PD-L1+ exosomes suppress immune cell cytotoxicity to permit tumor growth similar to PD-L1 expression on the tumor cell surface, and PD-L1+ exosomes appear promising predictors of clinical immunotherapy responses in patients21.